Complement Factor C4d Is a Common Denominator in Thrombotic Microangiopathy

Complement activation has a major role in thrombotic microangiopathy (TMA), a disorder that can occur in a variety of clinical conditions. Promising results of recent trials with terminal complement-inhibiting drugs call for biomarkers identifying patients who might benefit from this treatment. The...

詳細記述

保存先:
書誌詳細
出版年:J Am Soc Nephrol
主要な著者: Chua, Jamie S., Baelde, Hans J., Zandbergen, Malu, Wilhelmus, Suzanne, van Es, Leendert A., de Fijter, Johan W., Bruijn, Jan A., Bajema, Ingeborg M., Cohen, Danielle
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Nephrology 2015
主題:
Clinical Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4552108/
https://ncbi.nlm.nih.gov/pubmed/25573909
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2014050429
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料